Design and synthesis of novel benzo-dioxolane cyclooxygenase (COX-2) selective inhibitors.

被引:0
|
作者
Ezawa, M [1 ]
Khanapure, SP [1 ]
Garvey, DS [1 ]
Young, D [1 ]
Earl, RA [1 ]
Gaston, RD [1 ]
Fang, XQ [1 ]
Marek, P [1 ]
Shumway, M [1 ]
Trocha, M [1 ]
Janero, DR [1 ]
Letts, LG [1 ]
机构
[1] NitroMed Inc, Bedford, MA 01730 USA
来源
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2003年 / 225卷
关键词
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
243-MEDI
引用
收藏
页码:U217 / U218
页数:2
相关论文
共 50 条
  • [1] Structure based design of selective COX-2 inhibitors.
    Browner, MF
    FASEB JOURNAL, 1998, 12 (08): : A1304 - A1304
  • [2] Cellular mitogenesis is inhibited by selective cyclooxygenase-2 (COX-2) inhibitors.
    Longo, W
    Erickson, B
    Mazuski, J
    Panesar, N
    Deshpande, Y
    Kaminski, D
    GASTROENTEROLOGY, 1998, 114 (04) : A636 - A636
  • [3] Design and Synthesis of Imidazopyrazolopyridines as Novel Selective COX-2 Inhibitors
    Badrey, Mohamed G.
    Abdel-Aziz, Hassan M.
    Gomha, Sobhi M.
    Abdalla, Mohamed M.
    Mayhoub, Abdelrahman S.
    MOLECULES, 2015, 20 (08) : 15287 - 15303
  • [4] Structure-activity relationship of a series of novel bicyclic pyrazoles as selective cyclooxygenase-2 (COX-2) inhibitors.
    Garvey, DS
    Janero, DR
    Letts, LG
    Martino, AM
    Murty, MG
    Ranatunge, RR
    Richardson, SK
    Schroeder, JD
    Young, DV
    Zemtseva, IS
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 225 : U218 - U218
  • [5] Design and synthesis of 1,3-diarylurea derivatives as selective cyclooxygenase (COX-2) inhibitors
    Zarghi, Afshin
    Kakhgi, Samaneh
    Hadipoor, Atefeh
    Daraee, Bahram
    Dadrass, Orkideh G.
    Hedayati, Mehdi
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (04) : 1336 - 1339
  • [6] Comparative QSAR analyses of cyclooxygenase-2 (COX-2) inhibitors.
    Garg, R
    Kurup, A
    Mekapati, SB
    Hansch, C
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 221 : U436 - U436
  • [7] Perception of risk: the state of COX-2 selective inhibitors.
    Simon L.S.
    Strand V.
    Current Rheumatology Reports, 2005, 7 (3) : 163 - 166
  • [8] Computational approach to find selective COX-2 inhibitors.
    Kumar, M
    Zauhar, RJ
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 228 : U528 - U528
  • [9] Selective COX-2 inhibitors. Part 1: Synthesis and biological evaluation of phenylazobenzenesulfonamides
    Tsai, Wei-Jern
    Shiao, Young-Ji
    Lin, Shwu-Jiuan
    Chiou, Wen-Fei
    Lin, Lie-Chwen
    Yang, Tsang-Hsiung
    Teng, Che-Ming
    Wu, Tain-Shung
    Yang, Li-Ming
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (17) : 4440 - 4443
  • [10] Cyclooxygenase-2 (COX-2)-independent anticarcinogenic effects of selective COX-2 inhibitors
    Groesch, Sabine
    Maier, Thorsten Juergen
    Schiffmann, Susanne
    Geisslinger, Gerd
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2006, 98 (11): : 736 - 747